Malaria in the province of Huambo -Angola. Complications and therapeutic novelties
Abstract
Introduction: Malaria remains a priority public health issue in Angola. In Huambo province, there is a high disease burden, with significant clinical complications and challenges in diagnostic and therapeutic coverage. This study aims to describe the epidemiological, clinical, and healthcare situation of malaria in Huambo province through an observational, descriptive, and retrospective investigation that combined documentary review (2015–2025) with analysis of hospital records from the Hospital Geral do Huambo corresponding to the period November 25–28, 2024. Absolute frequencies and percentages of outpatient consultations, hospitalizations, malaria cases, and severe forms were analyzed.
In 2024, 967,000 confirmed cases were reported in the province, with 695 deaths (case fatality rate: 0.7 %). During the evaluated hospital period (96 hours), 2,508 patients were seen in the emergency department; 363 (14.5 %) were diagnosed with malaria, and 132 (36.4 % of malaria cases) corresponded to severe forms. The most frequent complications included cerebral malaria, severe anemia, and hypoglycemia, particularly in children under five years of age and pregnant women. Gaps persist in diagnostic confirmation and in the appropriate administration of artemisinin-based combination therapies (ACTs), especially in rural areas.
Malaria maintains high morbidity and mortality in Huambo, with a significant burden of severe disease that impacts hospital services.
Downloads
References
1.Severe Malaria Observatory. Angola: Malaria en Angola: estadísticas y datos; 2026 [citado 30/07/2025]; [aprox 4.p.]. Disponible en: https://www-severemalaria-org.translate.goog/countries/angola?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
2.Severe Malaria Observatory. Angola: Malaria fact 2024; 2024 [citado 30/07/2025]; [aprox 5.p.]. Disponible en: https://www.severemalaria.org/countries/angola
3.World Health Organization: addressing inequity in the global malaria response. Geneva: WHO; 2024[citado 30/07/2025]. Disponible en: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024
4.World Health Organization. World malaria report 2023. Geneva: WHO; 2023. [citado 30/07/2025]. Disponible en: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023
5.El País. Madrid: Ediciones el País [actualizado 11/12/2024; citado 4/10/2025]. El cambio climático, los conflictos y la desigualdad frenan los avances en la lucha contra la malaria; [aprox. 4 p.]. Disponible en: https://elpais.com/planeta-futuro/2024-12-11/el-cambio-climatico-los-conflictos-y-la-desigualdad-frenan-los-avances-en-la-lucha-contra-la-malaria.html
6.Das JK, Salam RA, Bhutta ZA. Malaria in pregnancy: meta-analyses of prevalence and associated complications. Epidemiol Infect. 2024[citado 4/10/2025];152:e39. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10945947/pdf/S0950268824000177a.pdf
7.National Library of Medicine. Bethesda: National Library of Medicine; [actualizado 26/2/2026; citado 4/10/2025]. R21/Matrix M malaria vaccine trials in African children (phase II/III); [aprox. 6 p.]. Disponible en: https://clinicaltrials.gov/study/NCT04704830
8.Duany Badell L, Sacanombo C, Cachequele André J, Kapinga Kapinga M, Joya Garcia J, Ukuessenje Isaac J. Perfil epidemiológico y entomológico de la malaria en la provincia Huambo. Angola, 2018. Medisur. 2021[citado 4/10/2025];19(4):580-9. Disponible en: https://www.medigraphic.com/pdfs/medisur/msu-2021/msu214g.pdf
9.Plucinski MM, Ferreira M, Ferreira CM, Burns J, Gaparayi P, João L., et al. Evaluating malaria case management at public health facilities in two provinces in Angola. Malaria journal. 2017[citado 4/10/2025];16(1):186. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC5415823/pdf/12936_2017_Article_1843.pdf
10.Médecins Sans Frontières. Geneva: Médecins Sans Frontières; [citado 4 sep 2025]. Relatório Anual 2018, Angola; [aprox 3 p.]. Disponible en: https://www.msf.org/pt-br/international-activity-report-2018/angola
11.Instituto Nacional de Estadística. Inquérito de Indicadores Múltiplos e de Saúde em Angola 2015–2016. Luanda: INE. 2017[citado 4/10/2025]. Disponible en: https://dhsprogram.com/pubs/pdf/fr327/fr327.pdf
12.Médicos Sin Fronteras. Argentina: Médicos Sin Fronteras; [actualizado 13/04/2018; citado 4/10/2025]. Angola: la malaria empieza a remitir en Huambo; [aprox 3 p.]. Disponible en: https://www.msf.org.ar/actualidad/angola-la-malaria-empieza-remitir-huambo/
13.Raymond Dango J, Tiandiogo Traore I, Clément Meda Z, Ouattara CHO, Kpadonou DM, Blaise Savadogo LG, et alPrognostic factors for death in patients
hospitalised with malaria in pediatric units at the regional hospital centre in Dori, Burkina Faso. BMC Infectious Diseases. 2024 [citado 4/10/2025];25:498. Disponible en: https://link.springer.com/content/pdf/10.1186/s12879-025-10909-3.pdf
14.World Health Organization. World malaria report 2020. Geneva: WHO; 2020. [citado 30/07/2025]. Disponible en: https://cdn.who.int/media/docs/default-source/malaria/world-malaria-reports/9789240015791-double-page-view.pdf?sfvrsn=2c24349d10
15.Morais I, Rodrigues S, Mas A, Escalon S, Borrego A, Nogueira F, et al. Severe malaria in Angola: the clinical profile and disease outcome among adults from a low-endemic area. Biomedicines. 2024[citado 4/09/2025];12(11):2639. Disponible en: https://www.mdpi.com/2227-9059/12/11/2639
16.Rodrigues ABB, de Abreu Fernandes R, Neto Z, Jandondo D, Almeida de Oliveira NK, de Lavigne Mello AR, et al. Pfkelch13 Plasmodium falciparum Mutations in Huambo, Angola. Pathogens. 2022[citado 4/09/2025];11(5):554. Disponible en: https://www.mdpi.com/2076-0817/11/5/554
17.Tavares W, Morais J, Martins JF, Scalsky RJ, Stabler TC, Medeiros MM, Fortes FJ, Arez AP, Silva JC. Malaria in Angola: recent progress, challenges and future opportunities using parasite demography studies. Malar J. 2022[citado 4/09/2025] ;21(1):396. Disponible en: https://link.springer.com/content/pdf/10.1186/s12936-022-04424-y.pdf
18.Idro R, Marsh K, John C. Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome. Pediatr Res. 2010 [citado 4/09/2025];68:267–74. Disponible en: https://www.nature.com/articles/pr2010173
19.Trivedi S, Chakravarty A. Neurological Complications of Malaria. Curr Neurol Neurosci Rep. 2022[citado 4/09/2025];22(8):499-513. Disponible en: https://www.researchgate.net/publication/361293045_Neurological_Complications_of_Malaria
20.Song x, Wei w, Cheng w, Zhu h, Wang W, Dong H, et al. Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Front Cell Infect Microbiol. 2022[citado 4/12/2025];12:939532. Disponible en: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2022.939532/full
21.Oyetunji Alabi A, Taye Oladibu O, Aderemi Ojedokun S, Ifeoluwa Akinbola A, Wulemot Oloyede T, et al. Childhood cerebral malaria: Pattern of biochemical parameters and clinical outcome in a Nigerian tertiary hospital. Clin Epidemiol Glob Health. 2024[citado 4/12/2025];30(101786). Disponible en: https://www.ceghonline.com/action/showPdf?pii=S2213-3984%2824%2900283-5
22.White NJ, Pira M. Malaria. En: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 21ª ed. Nueva York: McGraw-Hill;2022. [citado 4/12/2025];1286–99 p.
23.Kavanaugh MJ, Azzam SE, Rockabrand DM. Pruebas rápidas de diagnóstico de malaria: revisión bibliográfica y recomendación para un algoritmo de garantía y control de calidad. Diagnóstico (Basilea). 2021 [citado 4/12/2025];11(5)768. Disponible en: https://pmc-ncbi-nlm-nih-gov.translate.goog/articles/PMC8145891/?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
24.World Health Organization. Angola: WHO; 2025. [citado 4/12/2025]. World malaria report 2024. Disponible en: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024
25.Opoku Afriyie S, Addison TK, Badu K. Precisión del diagnóstico en pacientes con malaria clínica: comparación de la microscopía, las pruebas de diagnóstico rápido y una PCR cuantitativa de alta sensibilidad, analizando las implicaciones para las infecciones submicroscópicas. Malar J. 2023[citado 4/12/2025];22(76). Disponible en: https://link-springer-com.translate.goog/article/10.1186/s12936-023-04506-5?error=cookies_not_supported&code=73602519-4591-414b-96f9-c6dc3c018739&_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
26.Feleke DG, Alemu Y, Yemanebirhane N. Performance of rapid diagnostic tests, microscopy, loop-mediated isothermal amplification (LAMP) and PCR for malaria diagnosis in Ethiopia: a systematic review and meta-analysis. Malar J. 2021[citado 4/12/2025];20:384. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8474705/
27.Madkhali AM, Ghzwani AH, Al Mekhlafi HM. Comparación de la prueba de diagnóstico rápido, microscopía y reacción en cadena de la polimerasa para la detección de Plasmodium falciparum en una zona de baja transmisión, región de Jazan, suroeste de Arabia Saudita. Diagnostics. 2022[citado 4/12/2025]; 12(6):1485. Disponible en: https://www.mdpi.com/2075-4418/12/6/1485
28.Omari Aika AA, Gamble CL, Garner P. Artemether‐lumefantrine (six‐dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev. 2005[citado 4/12/2025];2025(4):CD009299. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6532733/
29.Nguyen TD, Davis TM, Ngo DT. Dihydroartemisinin–piperaquine for treatment of uncomplicated malaria: a systematic review and meta-analysis. Malar J. 2014[citado 4/12/2025];19(1):160. Disponible en: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-160
30.Severe Malaria Observatory. Angola: Angola, malaria facts. 2023. [citado 4/12/2025]; [aprox 4.p.]. Disponible en: https://www.severemalaria.org/countries/angola
31.Ministério da Saúde de Angola. Directrizes e normas de conduta para o diagnóstico e tratamento da malária. Angola: 2014. [citado 4/12/2025]. p.30. Disponible en: https://www.severemalaria.org/sites/default/files/content/document/Angola%20Manual%20de%20Tratamento%20da%20Mala_ria%202014_1.pdf
32.World Health Organization. Angola: WHO;2025[citado 4/03/2026]. Malaria vaccine implementation programme; [aprox 4.p.]. Disponible en: https://www.who.int/initiatives/malariavaccine-implementation-programme
33.RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without booster in African children. Lancet. 2015[citado 4/12/2025];386(9988):31-45. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC5626001/
34.Organización Mundial de Salud. Luanda, Angola: OMS;2025 [citado 4/03/2026]. Relatório anual; [aprox 38p.]. Disponible en: https://www.afro.who.int/sites/default/files/2026-02/Relat%C3%B3rio%20Anual%20de%20OMS%20Angola%202025_0.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maritza Alcaraz Agüero, Tomás Pell Frómeta

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
